课题基金 / 基金详情

Regulation of pre-mRNA splicing fidelity by the Nineteen Complex (NTC)

Regulation of pre-mRNA splicing fidelity by the Nineteen Complex (NTC)
十九复合物 (NTC) 对前 mRNA 剪接保真度的调节
批准号:
BB/I019510/1
负责人:
Raymond O'Keefe
金额:
$40.04万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2012
资助国家:
英国
项目状态:
已结题
起止时间:
2012 至 --

项目摘要

项目成果

Raymond O'Keefe的其他基金

相似基金

相关文献

中文摘要
翻译
细胞内的基因被复制到前信使RNA(前信使RNA)中,作为蛋白质生产的模板。基因中包含的所有信息并不是制造蛋白质所必需的。因此,在将其用于蛋白质生产之前,必须将不需要的信息从Pre-mRNA中移除。不想要的信息通过类似于剪辑电影中不想要的帧的过程从前信使核糖核酸中移除或‘拼接’。要移除的区域的一端首先被切割,然后另一端被切割,而剩下的两块被‘拼接’在一起。这种前信使核糖核酸的‘剪接’是非常重要的,因为它必须准确地发生,才能产生功能蛋白。剪接的调控对人类生物学的各个方面都是必不可少的。剪接是胚胎正常发育和所有组织和器官分化所必需的。对前mRNA剪接的调控对于生物体对环境的反应和适应压力和营养缺乏也是至关重要的。前信使核糖核酸剪接缺陷与多种疾病有关,包括糖尿病、癌症和年龄相关疾病。选择性剪接也使人类能够在不必增加基因组大小的情况下扩大细胞的复杂性。这里将进行的工作将解决剪接过程是如何发生的,因为关于如何调控前mRNA剪接仍然有一些关键的悬而未决的问题。剪接是由一个被称为剪接体的大型RNA/蛋白质复合体进行的。剪接体必须将自己排列成特定的构象,以识别并“拼接”出不需要的区域。越来越多的证据表明,与剪接体相关的一种称为19个复合体或NTC的蛋白质复合体是剪接体功能的重要调节因子。在这项提议之前的工作中,我们已经鉴定出一种名为Cwc2的NTC蛋白,它提供了NTC蛋白和剪接体活性部位之间的直接联系。发现NTC和剪接体之间的这种联系对于科学家现在如何理解前mRNA剪接调控的机制具有重要意义。由于我们是第一批发现这种联系的研究人员,我们现在有了一个优势,可以准确地发现这种联系是如何有助于调节前mRNA剪接的。在这项研究拨款期限内提出的工作将通过一系列详细的分子实验来解决Cwc2如何参与调节剪接的两个步骤所需的剪接体构象。由于Pre-mRNA剪接的基本机制在酵母和人类细胞中是相同的,因此我们在研究中避免使用动物,而是使用酵母细胞进行实验。
英文摘要
Genes within cells are copied into a pre-messenger RNA (pre-mRNA) which is used as a template for protein production. All the information contained within genes is not required for making proteins. The unwanted information, therefore, must be removed from the pre-mRNA before it is used for protein production. The unwanted information is removed, or 'spliced', from pre-mRNA by a process similar to the editing of unwanted frames from a film. One end of the region to be removed is first cut then the other end is cut while the two remaining pieces are 'spliced' together. This 'splicing' of the pre-mRNA is very important because it must occur accurately in order for functional proteins to be produced. The regulation of splicing is essential for all aspects of human biology. Splicing is required for proper embryo development and differentiation of all tissues and organs. Regulation of pre-mRNA splicing is also vital for organisms to respond to their environment and adapt to stresses and nutrient deprivation. Defects in pre-mRNA splicing are associated with a wide range of diseases including diabetes, cancer and age related diseases. Alternative splicing has also allowed humans to expand their cellular complexity without having to increase the size of their genome. The work that will be undertaken here will address how the process of splicing occurs as there are still some key unanswered questions on how pre-mRNA splicing is regulated. Splicing is carried out by a large RNA/protein complex called the spliceosome. The spliceosome must arrange itself into specific conformations to identify and 'splice' out the unwanted regions. An increasing amount of evidence points to a complex of proteins called the NineTeen Complex, or NTC, that associates with the spliceosome to act as an essential regulator of spliceosome function. In work leading up to this proposal we have identified an NTC protein called Cwc2 that provides the direct link between proteins of the NTC and the active site of the spliceosome. Discovering this link between the NTC and the spliceosome has implications for how scientists now understand the mechanisms of pre-mRNA splicing regulation. As we are the first researchers to discover this link we now have an advantage in discovering exactly how this link contributes to the regulation of pre-mRNA splicing. Work proposed during the tenure of this research grant will address how Cwc2 is involved in regulating spliceosome conformations required for the two steps of splicing through a set of detailed molecular experiments. As the basic mechanisms of pre-mRNA splicing are identical in yeast and human cells, we avoid using animals in our research by using yeast cells to perform our experiments .
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1080/15476286.2015.1008926
发表时间: 2015
期刊: RNA biology
影响因子: 4.1
作者: [de Almeida RA, O'Keefe RT]
通讯作者: O'Keefe RT
DOI: 10.1016/j.ajhg.2014.10.014
发表时间: 2014-12
期刊: American journal of human genetics
影响因子: 9.8
作者: [D. Wieczorek;W. Newman;T. Wieland;Tea Berulava;Maria Kaffe;D. Falkenstein;C. Beetz;E. Graf;T. Schwarzmayr;S. Douzgou;J. Clayton-Smith;Sarah B. Daly;S. Williams;S. Bhaskar;J. Urquhart;Beverley H Anderson;J. O’Sullivan;O. Boute;Jasmin Gundlach;J. Czeschik;A. V. van Essen;F. Hazan;Sarah S. Park;A. Hing;A. Kuechler;D. Lohmann;K. Ludwig;E. Mangold;L. Steenpass;M. Zeschnigk;J. Lemke;C. Lourenço;U. Hehr;E. Prott;M. Waldenberger;A. Böhmer;B. Horsthemke;R. O’Keefe;T. Meitinger;J. Burn;H. Lüdecke;T. Strom]
通讯作者: D. Wieczorek;W. Newman;T. Wieland;Tea Berulava;Maria Kaffe;D. Falkenstein;C. Beetz;E. Graf;T. Schwarzmayr;S. Douzgou;J. Clayton-Smith;Sarah B. Daly;S. Williams;S. Bhaskar;J. Urquhart;Beverley H Anderson;J. O’Sullivan;O. Boute;Jasmin Gundlach;J. Czeschik;A. V. van Essen;F. Hazan;Sarah S. Park;A. Hing;A. Kuechler;D. Lohmann;K. Ludwig;E. Mangold;L. Steenpass;M. Zeschnigk;J. Lemke;C. Lourenço;U. Hehr;E. Prott;M. Waldenberger;A. Böhmer;B. Horsthemke;R. O’Keefe;T. Meitinger;J. Burn;H. Lüdecke;T. Strom
DOI: 10.1093/nar/gku431
发表时间: 2014-07
期刊: Nucleic acids research
影响因子: 14.9
作者: [Hogg R, de Almeida RA, Ruckshanthi JP, O'Keefe RT]
通讯作者: O'Keefe RT
Understanding pre-mRNA splicing regulation with novel inhibitors
  • 批准号:
    BB/S00047X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $77.07万
  • 财政年份:
    2019
  • 负责人:
    Raymond O'Keefe
  • 依托单位:
Understanding the role of U5 snRNP gene mutation in pre-messenger RNA splicing and craniofacial development
  • 批准号:
    BB/N000358/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $57.44万
  • 财政年份:
    2016
  • 负责人:
    Raymond O'Keefe
  • 依托单位:
Investigating the role of the U2 and U6 snRNAs in exon ligation during pre-mRNA splicing
  • 批准号:
    BB/E000436/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $35.07万
  • 财政年份:
    2006
  • 负责人:
    Raymond O'Keefe
  • 依托单位:
国内基金
海外基金
肺癌CPSF3通过调控BCLAF1 pre-mRNA APA抑制NK细胞免疫监视的作
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    孟勐
  • 依托单位:
皮肤黑素瘤中 circROR1调控FOXO4 pre-mRNA可变 剪切促进肿瘤转移的机制研究
  • 批准号:
    2024JJ5541
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    谢慧清
  • 依托单位:
靶向SUV39H2 pre-mRNA 外显子跳跃逆转乳腺癌CDK4/6抑制剂耐 药的作用与机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    余诗奕
  • 依托单位:
HCMV 诱导动脉粥样硬化新机制:m6A 修饰诱导 FDXR pre-mRNA 可变剪切激活血管平滑肌增殖
  • 批准号:
    2024JJ5356
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    朱文博
  • 依托单位: